0001968582-23-000406.txt : 20230815 0001968582-23-000406.hdr.sgml : 20230815 20230815172454 ACCESSION NUMBER: 0001968582-23-000406 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230815 DATE AS OF CHANGE: 20230815 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 231175851 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Lalwani Nikhil CENTRAL INDEX KEY: 0001822629 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET CITY: BAUDETTE STATE: MN ZIP: 56623 144 1 primary_doc.xml 144 0001822629 XXXXXXXX LIVE 0001023024 ANI Pharmaceuticals, Inc. 001-31812 210 Main Street West Daudette MN 56623 218-634-3500 Nikhil S. Lalwani President, CEO Common JP Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

11616 708344 20280798 08/15/2023 NASDAQ Common 08/15/2023 Stock Option Exercise Issuer N 11616 08/15/2023 Cash N Nikhil S. Lalwani

C/o ANI Pharmaceuticals, Inc. 210 Main Street West Daudette MN 56623

Common 08/11/2023 56666 3272462 The options to be exercised within 3 months from the date of this filing. 08/15/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Nikhil S. Lalwani